Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure

Although third‐generation epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI) can overcome T790M‐mediated resistance in non‐small‐cell lung cancer (NSCLC), rebiopsy to confirm T790M status is occasionally difficult. We aimed to investigate the current tendency and the limitations...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Takahisa, Kenmotsu, Hirotsugu, Taira, Tetsuhiko, Omori, Shota, Nakashima, Kazuhisa, Wakuda, Kazushige, Ono, Akira, Naito, Tateaki, Murakami, Haruyasu, Mori, Keita, Nakajima, Takashi, Ohde, Yasuhisa, Endo, Masahiro, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946719/
https://www.ncbi.nlm.nih.gov/pubmed/27145431
http://dx.doi.org/10.1111/cas.12963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946719/
https://www.ncbi.nlm.nih.gov/pubmed/27145431
http://dx.doi.org/10.1111/cas.12963

Ejemplares similares